ICU Medical (NASDAQ: ICUI) VP logs equity award exercises and tax share dispositions
Rhea-AI Filing Summary
ICU Medical (ICUI) VP and General Counsel Virginia Ruth Sanzone reported equity award activity involving restricted and performance-based stock units. On March 7 and 8, 2026, she acquired multiple blocks of Common Stock through exercises or conversions of derivative awards, including 23,917 Performance Shares and several smaller tranches.
The filing also shows dispositions of Common Stock coded as tax-withholding events, with 13,221 shares and 1,762 shares delivered at a price of $132.00 per share to satisfy exercise price or tax liabilities. A performance stock unit grant dated March 8, 2024 was certified at 250% of target on February 11, 2026, resulting in the shares acquired. Footnotes explain that these awards are restricted stock units and performance-based restricted stock units with no purchase or exercise price and time-based vesting over three years.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Common Stock | 3,189 | $0.00 | -- |
| Exercise | Performance Shares | 23,917 | $0.00 | -- |
| Exercise | Common Stock | 23,917 | $0.00 | -- |
| Tax Withholding | Common Stock | 13,221 | $132.00 | $1.75M |
| Exercise | Common Stock | 3,189 | $0.00 | -- |
| Tax Withholding | Common Stock | 1,762 | $132.00 | $233K |
| Exercise | Common Stock | 2,348 | $0.00 | -- |
| Exercise | Common Stock | 2,348 | $0.00 | -- |
| Tax Withholding | Common Stock | 1,297 | $132.00 | $171K |
Footnotes (1)
- These securities are Restricted Stock Units. Represents the settlement of performance stock units granted on 3/8/2024. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 250% of target, resulting in the acquisition of the shares reported herein. There is neither a purchase price nor an exercise price for the Restricted Stock Units. One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. These are restricted stock units that fully vest 3 years from the grant date. These Securities are Performance-based Restricted Stock Units (PRSU). There is neither a purchase price nor an exercise price for the PRSUs.
